Where Hyaluronic Acid is reported
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Hepatitis C | ↑ elevated | healthy controls | — | Voumvouraki et al. 2011 |
| Osteoarthritis | ↓ reduced | OA synovial fluid vs normal | — | Moskowitz et al. 2000 |
Frequently asked questions
In which conditions is Hyaluronic Acid altered?
In the OSMF atlas Hyaluronic Acid is reported in Hepatitis C, Osteoarthritis. It is elevated in 1, reduced in 1 across 2 entries.
Does Hyaluronic Acid point to one specific diagnosis?
No. Because Hyaluronic Acid changes in several conditions (Hepatitis C, Osteoarthritis), an abnormal result cannot identify which condition, if any, is present. It must be interpreted with symptoms, history and other tests.
Is there a standard clinical test for Hyaluronic Acid?
The atlas entries for Hyaluronic Acid do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal Hyaluronic Acid result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.